Frequency and Characterization of Rare Histologic Subtypes in Canine Invasive Urothelial Carcinoma
Authors:
- Megan P. CorbettMCMegan P. Corbett
- Mohamed ElbadawyMEMohamed Elbadawy
- Andrew P. WoodwardAWAndrew P. Woodward
- John C. ChevilleJCJohn C. Cheville
- Hannah WickhamHWHannah Wickham
- Hannah NicholsonHNHannah Nicholson
- Michael CatucciMCMichael Catucci
- Bryan J. MelvinBMBryan J. Melvin
- Basant AhmedBABasant Ahmed
- Christopher ZdyrskiCZChristopher Zdyrski
- Lilian J. OliveiraLOLilian J. Oliveira
- Elizabeth W. HowerthEHElizabeth W. Howerth
Preprint
Abstract
The histologic and molecular heterogeneity of human muscle-invasive bladder cancer (MIBC) is a major contributor to poor treatment outcomes. While most cases of MIBC are diagnosed as conventional urothelial carcinoma (UC), there is growing recognition of histologic subtypes and divergent differentiation within conventional UC. This is clinically significant, as some require modification of therapy and some are associated with more aggressive behavior. Spontaneously occurring UC in dogs has been shown to exhibit histologic and molecular features that closely resemble those of human MIBC. In this study, we evaluated 31 canine UC tumor samples for histologic subtypes and divergent differentiation. Slides were reviewed by a human uropathologist and three board-certified veterinary pathologists and assessed for expression of uroplakin III and E-cadherin. All tumors were classified as high-grade UC. Fifteen cases were identified as conventional UC. Among the remainder, eight displayed glandular differentiation, four were classified as sarcomatoid UC, two showed squamous differentiation, and one case each was classified as large nested and tubular and microcystic subtypes. In summary, this study found a higher frequency of certain histologic subtypes and divergent differentiation in canine UC—particularly sarcomatoid UC and UC with glandular differentiation—compared to previous reports in both canine UC and human MIBC. Conclusion The relatively high prevalence of the sarcomatoid UC subtype in dogs observed in this study suggests that canine UC may serve as a valuable translational model for evaluating novel therapeutic agents, particularly for this rare and aggressive variant in humans.Keywords
This publication has 73 references indexed in Scilit:
- Prognostic Factors Influencing Postoperative Survival in Patients With Neuroendocrine Carcinoma of the Bladder: A Population‐Based StudyCancer Medicine, 2025
- The Lund taxonomy for bladder cancer classification – from gene expression clustering to cancer cell molecular phenotypes, and back againThe Journal of Pathology, 2023
- Clinicopathological Review of Micropapillary Urothelial CarcinomaCurrent Oncology Reports, 2022
- Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment ModalitiesClinical Genitourinary Cancer, 2021
- RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular SubtypeThe American Journal of Pathology, 2020
- Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder CancerCell Reports, 2019
- Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle‐invasive carcinoma of the bladder: Does histologic subtype matter?Cancer, 2019
- Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic reviewNeurourology and Urodynamics, 2017
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder CancerCell, 2017
- Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiationThe Journal of Pathology, 2007